Robert DeSantis - 23 Jul 2021 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role: EVP & Chief Product Officer
Signature: By: Donna Spinola For: Robert DeSantis
Issuer symbol: ISRG
Transactions as of: 23 Jul 2021
Net transactions value: -$3,035,650
Form type: 4
Filing time: 26 Jul 2021, 19:44:22 UTC
Next filing: 27 Aug 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ISRG	Common Stock	Options Exercise	$351,873	+484	+16%	$727.01	3,462	23 Jul 2021	Direct	F1
transaction	ISRG	Common Stock	Sale	$468,129	-484	-14%	$967.21	2,978	23 Jul 2021	Direct	F1, F2
transaction	ISRG	Common Stock	Options Exercise	$227,500	+422	+14%	$539.10	3,400	23 Jul 2021	Direct	F1
transaction	ISRG	Common Stock	Sale	$408,171	-422	-12%	$967.23	2,978	23 Jul 2021	Direct	F1, F2
transaction	ISRG	Common Stock	Options Exercise	$257,903	+483	+16%	$533.96	3,461	23 Jul 2021	Direct	F1
transaction	ISRG	Common Stock	Sale	$467,172	-483	-14%	$967.23	2,978	23 Jul 2021	Direct	F1, F2
transaction	ISRG	Common Stock	Sale	$2,529,453	-2,615	-88%	$967.29	363	23 Jul 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ISRG	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-483	-33%	$0.000000	967	23 Jul 2021	Common Stock	483	$533.96	Direct	F1, F3
transaction	ISRG	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-422	-29%	$0.000000	1,026	23 Jul 2021	Common Stock	422	$539.10	Direct	F1, F4
transaction	ISRG	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-484	-33%	$0.000000	965	23 Jul 2021	Common Stock	484	$727.01	Direct	F1, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 1, 2022.
F2	The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $962.83 to $975.41,inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3	Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
F4	Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and monthly thereafter, over a four year period of time.
F5	Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.